SEC Form 4 · accession 0001127602-18-009294

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 27, 2018

Accepted (ET)

Mar 1, 2018 · 12:15 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 27, 2018	S	100	$107.815	D	321,607	D
Common Stock	Feb 27, 2018	S	260	$107.82	D	321,347	D
Common Stock	Feb 27, 2018	S	200	$107.825	D	321,147	D
Common Stock	Feb 27, 2018	S	200	$107.83	D	320,947	D
Common Stock	Feb 27, 2018	S	500	$107.84	D	320,447	D
Common Stock	Feb 27, 2018	S	500	$107.86	D	319,947	D
Common Stock	Feb 27, 2018	S	200	$107.87	D	319,747	D
Common Stock	Feb 27, 2018	S	200	$107.88	D	319,547	D
Common Stock	Feb 27, 2018	S	200	$107.89	D	319,347	D
Common Stock	Feb 27, 2018	S	200	$107.90	D	319,147	D
Common Stock	Feb 27, 2018	S	300	$107.91	D	318,847	D
Common Stock	Feb 27, 2018	S	200	$107.915	D	318,647	D
Common Stock	Feb 27, 2018	S	230	$107.92	D	318,417	D
Common Stock	Feb 27, 2018	S	100	$107.925	D	318,317	D
Common Stock	Feb 27, 2018	S	303	$107.93	D	318,014	D
Common Stock	Feb 27, 2018	S	100	$107.935	D	317,914	D
Common Stock	Feb 27, 2018	S	100	$107.945	D	317,814	D
Common Stock	Feb 27, 2018	S	600	$107.95	D	317,214	D
Common Stock	Feb 27, 2018	S	300	$107.955	D	316,914	D
Common Stock	Feb 27, 2018	S	300	$107.96	D	316,614	D
Common Stock	Feb 27, 2018	S	100	$107.97	D	316,514	D
Common Stock	Feb 27, 2018	S	500	$107.99	D	316,014	D
Common Stock	Feb 27, 2018	S	200	$108.00	D	315,814	D
Common Stock	Feb 27, 2018	S	100	$108.02	D	315,714	D

No Table II lines on this filing.